- Home
- HNW vs ADAG Comparison
HNW vs ADAG Comparison
Compare HNW & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNW
- ADAG
- Stock Information
- Founded
- HNW 2007
- ADAG 2011
- Country
- HNW United States
- ADAG China
- Employees
- HNW N/A
- ADAG N/A
- Industry
- HNW Finance/Investors Services
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- HNW Finance
- ADAG Health Care
- Exchange
- HNW Nasdaq
- ADAG Nasdaq
- Market Cap
- HNW 102.6M
- ADAG 98.3M
- IPO Year
- HNW N/A
- ADAG 2021
- Fundamental
- Price
- HNW $12.22
- ADAG $2.21
- Analyst Decision
- HNW
- ADAG Strong Buy
- Analyst Count
- HNW 0
- ADAG 1
- Target Price
- HNW N/A
- ADAG $5.00
- AVG Volume (30 Days)
- HNW 25.7K
- ADAG 75.1K
- Earning Date
- HNW 01-01-0001
- ADAG 07-25-2024
- Dividend Yield
- HNW 9.21%
- ADAG N/A
- EPS Growth
- HNW N/A
- ADAG N/A
- EPS
- HNW 1.19
- ADAG N/A
- Revenue
- HNW N/A
- ADAG $815,746.00
- Revenue This Year
- HNW N/A
- ADAG N/A
- Revenue Next Year
- HNW N/A
- ADAG $2.70
- P/E Ratio
- HNW $9.85
- ADAG N/A
- Revenue Growth
- HNW N/A
- ADAG N/A
- 52 Week Low
- HNW $9.80
- ADAG $1.35
- 52 Week High
- HNW $11.76
- ADAG $4.38
- Technical
- Relative Strength Index (RSI)
- HNW 49.40
- ADAG 34.38
- Support Level
- HNW $12.25
- ADAG $2.01
- Resistance Level
- HNW $12.47
- ADAG $2.41
- Average True Range (ATR)
- HNW 0.09
- ADAG 0.30
- MACD
- HNW -0.01
- ADAG -0.09
- Stochastic Oscillator
- HNW 50.22
- ADAG 10.83
About HNW Pioneer Diversified High Income Fund Inc.
Pioneer Diversified High Income Trust is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income as well as capital appreciation. The company invests in various sectors such as Health Care Technology, Household Durables, Oil, Gas and Consumable Fuels, Specialty Retail, Banks, Chemicals, Financial Services, and others. It also invests in convertible bonds, common stock, asset-backed securities, and the U.S Treasury.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.